Overview of guests invited by the RTG Chembion
Date | Name | Affiliation | Title |
18.11.2024 | Prof. Dr. Gunda Georg | Department of Medicinal Chemistry, Institute for Therapeutics Discovery and Development, University of Minnesota, USA |
Sperm-specific ion channels as targets for male non-hormonal contraceptives |
11.11.2024 | Prof. Dr. Kasper Hansen |
Center for Structural and Functional Neuroscience , |
Subtype-specific modulation of neuronal NMDA receptors |
02.10.2024 |
Prof. Tim Donohoe |
Department of Chemistry, University of Oxford |
Hydride transfer methodology and an approach to the octahydronaphthalene class of natural products |
30.08.2024 | Prof. Jonathan Marchant |
Marcus Chair of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin |
"Target based drug discovery for neglected tropical diseases" |
11.07.2024 | Dr. Yvonne Börgeling | Zentrum für Molekularbiologie der Entzündung | "Novel therapeutic strategies for the treatment of respiratory infections" |
12.06.2024 | Dr. Alessio Accardi |
Weill Cornell Medicine, New York, NY, United States |
"In or out of the groove? How the TMEM16s flip lipids" |
13.05.2024 |
Prof. Dr. Celia Santi |
Department of Obstetrics and Gynecology |
"SLO3 K+ channels in Male Fertility and Contraception" |
24.04.2024 | Dr. Dimitrii Kalinin |
Institut für Pharmazeutische und Medizinische Chemie, Universität Münster |
"Microscale Reactions to Target Blood Coagulation Enzymes and Platelet P2X1 Receptors" |
28.02.2024 | Dr. Line Næsborg |
Organisch-Chemisches Institut, Universität Münster |
"Micellar Effects on Photochemical Reactions." |
27.02.2024 | Prof. Dr. Thomas Gudermann |
Walther Straub Institute of Pharmacology and Toxicology Faculty of Medicine, LMU Munich |
"Targeting TRP Channels." |
13.11.2023 |
Dr. Lydie Plecita-Hlavata |
Institute of Physiology, Czech Academy of Sciences |
"The role of NOX4 and redox signaling in physiology and pathology of pancreatic beta cells." |
10.11.2023 | Prof. Dr. Sergey N. Krylov |
Centre for Research on Biomolecular Interactions York University, Toronto, Ontario, Canada |
"Analytical Challenges of Preparing for the Next Pandemic" |
03.11.2023 |
Prof. Dr. Sergey N. Krylov |
Centre for Research on Biomolecular Interactions York University, Toronto, Ontario, Canada |
"Accuracy of determined KD values" |
17.10.2023 | Prof. Dr. Peter Jedlicka |
Computer-Based Modelling Justus Liebig Universität, Gießen |
"Biophysical and morphological models of nerve cells reveal general principles of their operation." |
12.10.2023 | Prof. Dr. Thomas Andrew Qvistgaard Jepps |
Department of Biomedical Sciences University of Copenhagen |
"(Patho)physiology of Kv7 ion channels." |
02.10.2023 | Prof. Dr. Mette Homann Poulsen |
Center for Biopharmaceuticals University of Copenhagen, Denmark |
"Channel-transporter crosstalk." |
14.06.2023 |
Prof. Dr. György Panyi |
University of Debrecen Hungary |
"Tools for targeting voltage-gated and Ca2+-activated K+ channels." |
24.05.2023 | Prof. Dr. Ivan Bogeski |
Heart Center Göttingen, Department of Cardiovascular Physiology, University Medical Center Göttingen |
"'Exploring the role of calcium and redox signals in immunity and cancer." |
05.04.2023 | Dr. Thomas Müller |
Head of Cell Biology, Research & Development, Bayer AG |
"The joy and sorrow of being a Pharma drug hunter – 15 years of BAYER KCNNK3 high-throughput molecular Pharmacology" |
15.03.2023 |
Dr. Markus Schewe |
Institute of Physiology, Kiel University |
"Ion channels on drugs: Structure-function and pharmacology of two-pore domain potassium (K2P) channels" |
13.03.2023 |
Prof. Dr. Stefan Feske |
NYU Grossmann School of Medicine, Department of Pathology, New York University, USA |
“Ion Channels and Transporters in immune cells and immunity“ |
01.02.2023 |
Prof. Dr. José L. Medina-Franco |
School of Chemistry, UNAM, Mexico |
"Progress on epigenetic drug discovery with epi-informatics" |
16.02.2023 | Prof. Dr. Stefan Laufer | Pharmazeutisches Institut, Eberhard-Karls-Universität Tübingen |
"Targeting the R-Spine: Design, Synthesis and Biological Evaluation of Novel Type I½ p38α MAP Kinase Inhibitors with Excellent Selectivity, High Potency and Prolonged Target Residence Time: Implication for Cancer- and CNS-Applications" |
24.01.2023 | Prof. Dr. Joseph Moran | University of Strasbourg & CNRS, France | 'Nonenzymatic Metabolic Reactions and Life's Origins' |
09.01.2023 | Prof. Dr. Herbert Waldmann | MPI in Dortmund | „Pseudo-Natural Products - Chemical Evolution of Natural Product Structure“ |
2022 | |||
07.12.2022 | Prof. Dr. Niels Decher | Department of Physiology and Pathophysiology Philipps-Universität Marburg | "The mechanism of Lipid-Induced Kv Channel Inhibition" |
16.11.2022 |
Dr. Michael Pusch |
Institute of Biophysics Italian National Research Council Genova, Italy |
'Endo- / lysosomal CLC transporters: from biophysics to human neurological diseases' |
12.10.2022 | Prof. Dr. Francisco J. Urbano |
IFIBYNE-CONICET University City Buenos Aires, Argentina |
'Gamma band activity of the Pedunculopontine Nucleus during waking and sleep: Taking advantage of in vitro techniques' |
05.10.2022 | Prof. Dr. Francisco J. Urbano |
IFIBYNE-CONICET University City Buenos Aires, Argentina |
'Characterization of leptin effects on thalamocortical neurons using slices in vitro' |
13.07.2022 | Jun.-Prof. Dr. Matthias Gehringer | Medizinische Chemie und Chemische Biologie Pharmazeutisches Institut Eberhard Karls Universität Tübingen |
"Targeting the Protein Kinases Cysteinome with Canonical and Noncanonical Covalent Warheads" |
13.06.2022 joint GDCh, CRC 1348, Chembion and CRC 858 lecture |
Prof. Dr. Neal K. Devaraj | University of California, San Diego (UCSD), USA | "Membrane mimetic chemistry for artificial cells" |
31.05.2022 joint PharmaCampus Kolloquium and Chembion Seminar |
Prof. Dr. Laura Mercolini | University of Bologna - Department of Pharmacy and Biotechnology (FaBiT) | “Methods to quantify drugs in biological fluids from small sample volumes.” |
24.05.2022 joint PharmaCampus Kolloquium and Chembion Seminar |
Dr. Michael Schulte | Merck KGaA | „390 Jahre Chinin - die lange Karriere eines besonderen Arzneistoffes“ |
19.05.2022 | Prof. Dr. Dr. Dr. Sven Meuth |
Klinik für Neurologie Universitätsklinikum Düsseldorf |
'Ion modulation in MS' |
17.03.2022 | Prof. Dr. Petra Dersch | Institut für Infektiologie, WWU Münster | 'Structural-functional analysis of crucial virulence factors of Yersinia.' |
23.02.2022 |
Dr. Annika Lüttjohann |
Institute for Physiology I, WWU Münster |
'Generation and generalization mechanisms of absence seizures.' |
08.02.2022 3rd Chembion Symposium |
Prof. Dr. Dario DiFrancesco |
Università degli Studi di Milano |
'Funny current/HCN channels in health and disease: a 40-year journey' |
08.02.2022 3rd Chembion Symposium |
Prof. Dr. Ivana Novak |
Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Denmark |
'Purinergic signaling in pancreas - in health and disease' |
08.02.2022 3rd Chembion Symposium |
Associate Prof. Dr. Alessandra Fiorio Pla | Department of Life Science and Systems Biology, and Nanostructured Interfaces and Surfaces Centre of Excellence (NIS), University of Torino, Italy | 'TRPM8-Rap1 interaction plays a key protective role in angiogenesis and cancer cells migration' |
08.02.2022 3rd Chembion Symposium |
Prof. Dr. Patrik Rorsman |
Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, UK |
'Causes and treatment of diabetes: role of ion channels' |
02.02.2022 | Dr. Maren Lindner | Klinik für Neurologie mit Institut für Translationale Neurologie Uniklinikum Münster |
'The underestimated role of T cells in neuromyelitis optica (NMO).' |
26.01.2022 | PD Dr. Stjepana Kovac | Klinik für Neurologie mit Institut für Trans-lationale Neurologie Uniklinikum Münster |
'Reactive oxygen species and hyperexcitability.' |
2021 | |||
15.12.2021 | Prof. Dr. Justin Du Bois | Department of Chemistry, Stanford University, USA | 'Using Chemistry to Study Voltage-Gated Sodium Channels.' |
17.11.2021 | Prof. Dr. Alistair Mathie | Medway School of Pharmacy The Universities of Greenwich and Kent at Medway, UK |
'Pharmacological approaches to studying potassium channels.' |
27.10.2021 | Prof. Dr. Stefan Huber | Universitätsklinik für Radioonkologie Universitätsklinikum Tübingen |
'Neuro-oncology of IK and BK Calcium-Activated Potassium Channels' |
01.09.2021 | Dr. Ahmed Haider | Harvard Medical School, Massachusetts General Hospital, Department of Radiology, Boston, USA | 'Subtype-Selective NMDA Receptor Imaging with Positron Emission Tomography – From Molecular Concepts to Precision Medicine.' |
30.06.2021 | Prof. Dr. Michael Ziller | Lab for Functional Genomics in Psychiatry, WWU Münster | 'Dissecting the polygenic basis of schizophrenia using pluripotent stem cells and functional genomics.' |
23.06.2021 | Asst. Prof. Dr. Matthew Eddy | Chemistry – Chemical Biology Division, University of Florida | 'Mechanisms of Allosteric Modulation of Human GPCRs by Small Molecules and Cellular Lipids' |
16.06.2021 | Prof. Dr. Bryan Roth | Department of Pharmacology, Eshelman School of Medicine, University of North Carolina at Chapel Hill |
'Structure-guided GPCR drug discovery' |
05.05.2021 | Dr. Kenneth A. Jacobson | Laboratory of Bioorganic Chemistry National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, USA |
'Design and therapeutic potential of purinergic receptor ligands.' |
21.04.2021 | PD Dr. Ursula Storch | Walther-Straub-Institut für Pharmakologie und Toxikologie / IPEK Ludwig-Maximilians-Universität München |
'Molecular insights into receptor-operated TRPC channel activation' |
07.04.2021 | Prof. Dr. Alan Kay | University of Iowa, Department of Biology, Iowa City, USA | 'Why K+?' |
03.03.2021 | Prof. Dr. Patrick Bednarski | Pharmaceutical/Medicinal Chemistry, University of Greifswald, Greifswald | 'Pentathiepins: New anticancer agents?' |
17.02.2021 | Prof. Dr. Christos Gatsogiannis | Centre for Theoretical Medicine, Institute for Medical Physics and Biophysics, WWU Münster | 'Structural Biology in the era of cryoEM.' |
09.02.2021 2nd Chembion Symposium |
Prof. Dr. Daniel Minor | University of California, USA | 'K2P Channel Gating - Caught in the Act' |
09.02.2021 2nd Chembion Symposium | Prof. Dr. John White | Boston University, USA | 'Engineering Approaches to Understand Functional Connectivity in Neocortex' |
09.02.2021 2nd Chembion Symposium | Prof. Dr. Ildikò Szabò | University of Padova, Italy | 'Mitochondrial Ion Channel in Cancer' |
09.02.2021 2nd Chembion Symposium | Dr. Pierre Paoletti | Institut de Biologie de l'École Normale Supérieure, Paris, France | 'Illuminating NMDA receptor structure and function using molecular optogenetics' |
03.02.2021 | Prof. Dr. Luis A. Pardo | Max-Planck-Institute of Experimental Medicine, Göttingen | 'Targeting the voltage-gated potassium channel KV10.1 for cancer therapy?' |
2020 | |||
08.12.2020 | Prof. Dr. Eric Beitz | Christian-Albrechts-Universität Kiel | 'Novel anti-malarial compounds inhibit the parasite's lactate/H+ transporter.' |
25.11.2020 | Dr. Felix Neumaier | Forschungszentrum Jülich | 'Role of Zn2+ and Cu2+ in the central nervous system.' |
24.11.2020 | Prof. Dr. Heike Wulff | University of California, Davis, USA | 'KCa3.1 ion channel, an overview of blockers and activators.' |
28.10.2020 | Assoc. Prof. Dr. V'yacheslav Lehen'kyi | Université de Lille, France | 'TRPV6 calcium channel as a prospective pharmacological target in cancer' |
30.09.2020 1st Chembion Retreat |
Dr. Reinhard Seifert | Forschungszentrum caesar, Bonn | 'Even funnier: Hyperpolarization-activated channels selective for protons' |
30.09.2020 1st Chembion Retreat |
Prof. Dr. Tanja Kuhlmann | WWU Münster | ‘How to wrap the myelin: What can we learn from stem cells?' |
29.09.2020 1st Chembion Retreat |
Prof. Dr. Eric Gouaux | Vollum Institute, Portland, USA | 'How ionotropic glutamate receptors work' |
29.09.2020 1st Chembion Retreat |
Prof. Dr. Daniel Kümmel | WWU Münster | ‘Peptide inhibitors of the α-cobratoxin/nicotinic acetylcholine receptor interaction’ |
16.09.2020 | Prof. Dr. Evan Miller | University of California, Berkeley, USA | 'Electrophysiology, Unplugged: New Chemical Tools to Visualize Cellular Physiology' |
31.08.2020 | Prof. Dr. Christina Chai | National University of Singapore, Singapore | ‘Harnessing the power of natural products: Andrographolide as lead compound in the development of anti-inflamatory agents.’ |
22.07.2020 | Prof. Dr. Dr. h.c. Herbert Waldmann | Max Planck Institute of Molecular Physiology, Dortmund | 'Pseudo Natural Products - Chemical Evolution of Natural Product Structure.' |
01.07.2020 | Prof. Dr. Yasushi Okamura | Osaka University, Japan | 'Where PIs are located will matter: Voltage sensing phosphatase regulates subcellular distribution of phosphoinositides in sperm membrane to regulate sperm motility.' |
05.06.2020 1st Chembion Symposium | Prof. Dr. Annarosa Arcangeli | University of Firenze, Italy | 'Targeting hERG1 channels for a therapeutic approach to cancer' |
05.06.2020 1st Chembion Symposium | Prof. Dr. Giuseppe Melacini | McMaster University, Canada | 'Mechanisms for HCN gating' |
26.02.2020 | Prof. Dr. Boris Musset | Paracelsus Medizinische Privatuniversität, Klinikum Nürnberg | ‘Structure and function of voltage-gated proton channels.’ |
27.01.2020 | Prof. Dr. Martin Biel | Ludwig-Maximilians-Universität München | 'Ion channels: from molecules to bedside' |
2019 | |||
04.12.2019 | Prof. Dr. Arnd Baumann | Forschungszentrum Jülich | 'Role of HCN channels in hippocampal neurons.' |
20.11.2019 | Prof. Dr. Bodo Laube | Technische Universität Darmstadt | 'NMDA receptor mediated signaling in health and disease.' |
07.11.2019 | Dr. Jennifer Hughes | University of Illinois at Urbana-Champaign, USA | 'Illuminating the Sperm-Oviduct Reservoir: Use of flow cytomerty, multiphotonic and superresolution imaging in the porcine model.' |